Article
DTNBP1 (dysbindin) gene variants: in vivo evidence for effects on hippocampal glutamate status.
Current pharmaceutical biotechnology - 1 Jun 2012
Wirth C, Schubert F, Lautenschlager M, Brühl R, Klär A, Majic T, Lang U E, Ehrlich A, Winterer G, Sander T, Schouler-Ocak M, Gallinat J
Abstract excerpt
INTRODUCTION: In linkage and association studies the DTNBP1 gene has been identified as a major susceptibility gene for schizophrenia. Reduced expression of DTNBP1 was found in the hippocampus and prefrontal cortex in post mortem brains of schizophrenic patients. In vitro and animal models provide evidence that the DTNBP1 gene product dysbindin modulates the activity of the neurotransmitter glutamate in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
